| CAS NO: | 4425-23-4 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 50mg | 电议 |
| 500mg | 电议 |
RLX is an inhibitor of PI3K/akt/FoxO3a signalling in experimental colon cancer. References: Garella R, Squecco R, Baccari MC. Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report. Curr Protein Pept Sci. 2017;18(12):1254-1262. doi: 10.2174/1389203718666170612104719. Review. PubMed PMID: 28606038.
纯度：≥98%
CAS：4425-23-4
m.cnreagent.com